Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Treasury Shares (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Treasury Shares for 10 consecutive years, with $522498.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 17.62% to $522498.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $522498.0 through Dec 2025, up 17.62% year-over-year, with the annual reading at $522498.0 for FY2025, 17.62% up from the prior year.
  • Treasury Shares for Q4 2025 was $522498.0 at Cartesian Therapeutics, roughly flat from $523254.0 in the prior quarter.
  • The five-year high for Treasury Shares was $2.5 million in Q1 2023, with the low at $394450.0 in Q4 2021.
  • Average Treasury Shares over 5 years is $984818.7, with a median of $561888.0 recorded in 2021.
  • The sharpest move saw Treasury Shares surged 470.8% in 2021, then crashed 81.16% in 2024.
  • Over 5 years, Treasury Shares stood at $394450.0 in 2021, then soared by 332.39% to $1.7 million in 2022, then increased by 20.37% to $2.1 million in 2023, then crashed by 78.36% to $444238.0 in 2024, then rose by 17.62% to $522498.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $522498.0, $523254.0, and $533331.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.